Yoon Yeo modified nanoparticles (IMAGE)
Caption
Purdue University researchers are developing and validating patent-pending nanoparticles (left) to enhance immunotherapy effects against tumors. The nanoparticles are modified with adenosine triphosphate, or ATP, to recruit dendritic cells (right), which are immune cells that recognize tumor antigens and bring specialized immune cells to fight off tumors.
Credit
(Images provided by Yoon Yeo)
Usage Restrictions
None
License
Original content